A New Prognostic Model for Predicting Outcomes of Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Receiving Subsequent Line (≥2 Lines) Anti-Programmed Death-1 Monotherapy.
Oral Oncology（2023）
Key words
Camrelizumab,Immune checkpoint inhibitor,Metastasis,Nasopharyngeal carcinoma,Nivolumab,Nomograms,Recurrence,Toripalimab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined